Preclinical Innovation Think Tanks

Servicecore – Do not remove

Preclinical Innovation Think Tanks

Preclinical Innovation Think Tanks

Core Image

Indiana University, Purdue University, University of Notre Dame

Drug Think Tank Chair:

Andrew Dahlem, PhD

Drug Think Tank Co-Chair:

Richard Taylor, PhD

Device Think Tank Chair:

Andrew Brightman, PhD

Device Think Tank Co-Chair:

Thomas O'Sullivan, PhD


The Indiana CTSI Preclinical Innovation “Think Tank” program will serve as a one-stop-shop where PIs can receive guidance from a pool of advisors – including experts in the drug and device industry – who serve as an essential resource for a wide range of scientific, technical, clinical, business, and regulatory questions. Projects will be guided from start to finish with robust tracking and milestone-based funding to help generate data for Investigational New Drug (IND) or Investigational Device Exemption (IDE) applications, small business grants such as the NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs, or commercialization.

|2024-02-20T16:42:28-05:00January 17th, 2024|Comments Off on Preclinical Innovation Think Tanks

Get Involved with Indiana CTSI